VERTESY Laszlo | LG Natural Product Research
スポンサーリンク
概要
関連著者
-
Vertesy Laszlo
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
VERTESY Laszlo
LG Natural Product Research
-
Kurz M
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Kurz M
Aventis Pharma Frankfurt Am Main Deu
-
Kurz Michael
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Knauf M
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Ehrlich Klaus
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Wink Joachim
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Seibert G.
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Schummer Dietmar
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Schiell Matthias
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Vogel Martin
Aventis Pharma Deutschland Gmbh Global Preclinical Development Analytics
-
Kogler H
Aventis Pharma Deutschland Gmbh
-
Kurz Michael
Aventis Pharma
-
Markus Astrid
Aventis Pharma Deutschland Gmbh
-
SCHUMMER DIETMAR
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
BARBONE Francis
Aventis Pharmaceuticals Inc.
-
CASHMEN Elizabeth
Aventis Pharmaceuticals Inc.
-
DECKER Heinrich
Aventis Pharma Deutschland GmbH
-
EHRLICH Klaus
Drug Innovation & Approval
-
JORDAN Birgit
Drug Innovation & Approval
-
KNAUF Martin
Drug Innovation & Approval
-
SCHUMMER Dietmar
Drug Innovation & Approval
-
SEGETH Marian
Drug Innovation & Approval
-
WINK Joachim
Drug Innovation & Approval
-
SEIBERT Gerhard
Drug Innovation & Approval
-
Segeth Marian
Aventis Pharma Deutschiand Gmbh Drug Innovation & Approval
-
KOGLER Herbert
Aventis Pharma Deutschland GmbH
-
VOGEL Martin
Global Pharmaceutical Development Analytical Sciences
-
SEIBERT Gerhard
Aventis Pharma Deutschland GmbH, Division Lead Generation
-
BECK Bernd
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
BRONSTRUP Mark
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
MULLER Gunter
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
Broenstrup M
Aventis Pharma Deutschland Gmbh Frankfurt/main Deu
-
Beck Bernd
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Muller Gunter
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Jordan Birgit
Drug Innovation & Approval
著作論文
- Pluraflavins, Potent Antitumor Antibiotics from Saccharothrix sp. DSM 12931
- Memnopeptide A, a Novel Terpene Peptide from Memnoniella with an Activating Effect on SERCA2
- Cyclipostins, Novel Hormone-sensitive Lipase Inhibitors from Streptomyces sp. DSM 13381 II. Isolation, Structure Elucidation and Biological Properties